Capital International Sarl - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International Sarl ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$683,544
-30.3%
297,193
-2.4%
0.05%
-39.2%
Q3 2022$981,000
-41.0%
304,582
+0.8%
0.08%
-40.6%
Q2 2022$1,662,000
+212.4%
302,182
+32.4%
0.13%
+411.5%
Q1 2022$532,000
-59.9%
228,149
+3.9%
0.03%
-58.7%
Q4 2021$1,327,000
-40.0%
219,641
+37.7%
0.06%
-67.9%
Q3 2021$2,212,000
+18.1%
159,491
+10.7%
0.20%
+21.0%
Q2 2021$1,873,000
-8.7%
144,055
+8.1%
0.16%
-17.3%
Q1 2021$2,052,000133,2760.20%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 10,881,144$31,337,6953.43%
Sio Capital Management, LLC 2,081,216$5,993,9021.86%
Pivotal bioVenture Partners Investment Advisor LLC 1,375,000$3,960,0001.58%
TCG Crossover Management, LLC 3,038,889$8,752,0001.29%
Logos Global Management LP 2,525,000$7,272,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 1,531,497$4,410,7110.80%
Orbimed Advisors 9,308,726$26,809,1310.57%
GREAT POINT PARTNERS LLC 579,667$1,669,4410.30%
Temasek Holdings (Private) Ltd 9,901,940$28,517,5870.17%
TANG CAPITAL MANAGEMENT LLC 159,087$458,1710.06%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders